Lundbeck
HLUN-B.CO
#2582
Rank
โ‚ฌ5.14 B
Marketcap
5,40ย โ‚ฌ
Share price
-0.98%
Change (1 day)
23.52%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.60 Billion

According to Lundbeck 's latest financial reports the company's total debt is โ‚ฌ0.60 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ0.55 B-25.75%
2022-12-31โ‚ฌ0.74 B4.69%
2021-12-31โ‚ฌ0.71 B-32.53%
2020-12-31โ‚ฌ1.06 B-17.29%
2019-12-31โ‚ฌ1.28 B
2018-12-31N/A-100%
2017-12-31โ‚ฌ7.65 M-97%
2016-12-31โ‚ฌ0.25 B-49.49%
2015-12-31โ‚ฌ0.50 B12.55%
2014-12-31โ‚ฌ0.44 B55.03%
2013-12-31โ‚ฌ0.28 B13.16%
2012-12-31โ‚ฌ0.25 B-0.64%
2011-12-31โ‚ฌ0.25 B-0.54%
2010-12-31โ‚ฌ0.25 B-44.58%
2009-12-31โ‚ฌ0.46 B82.69%
2008-12-31โ‚ฌ0.25 B2.38%
2007-12-31โ‚ฌ0.24 B29.73%
2006-12-31โ‚ฌ0.19 B275.25%
2005-12-31โ‚ฌ51.31 M-6.81%
2004-12-31โ‚ฌ55.06 M